Patents Assigned to WASHINGTON UNIVERSITY IN SAINT LOUIS
  • Patent number: 10945999
    Abstract: The present disclosure provides a combination comprising: (i) a drug against tuberculosis, or a pharmaceutically acceptable salt thereof, and (ii) a compound of Formula II, or a pharmaceutically acceptable combination thereof. The combination may be used in the treatment and/or prevention of tuberculosis.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: March 16, 2021
    Assignees: QURETECH BIO AB, WASHINGTON UNIVERSITY IN SAINT LOUIS
    Inventors: Christina L. Stallings, Fredrik Almqvist, Kelly Flentie, James Arthur Dudley Good, Fritiof Ponten
  • Publication number: 20120040357
    Abstract: In one aspect, the disclosure provides isolated nucleic acids, primers, and probes for the detection of mutations in a nucleic acid sequence for a DICER1 polypeptide.
    Type: Application
    Filed: December 18, 2009
    Publication date: February 16, 2012
    Applicants: THE WASHINGTON UNIVERSITY IN SAINT LOUIS, CHILDREN'S HOSPITAL AND CLINICS OF MINNESOTA
    Inventors: Ashley D. Hill, Paul Goodfellow, John R. Priest, Yoav Messinger